No Association Between HLA-B*57:01 and Prevalence and/or Outcome of Progressive Multifocal Leukoencephalopathy in a French Nationwide Human Immunodeficiency Virus Cohort

Progressive multifocal leukoencephalopathy in patients with immuno-virological control and at least 6 months of combination antiretroviral therapy

(2021) Paul Dalla-Pozza et al.   AIDS

The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function

(2020) Philippa M. Saunders et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Factors associated with psoriasis in a French Nationwide HIV cohort

(2020) Maxime Hentzien et al.   AIDS

The novel HLA‐B *57:135 allele was identified during high‐resolution HLA typing

(2020) Maria Loginova et al.   HLA

Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4)

(2018) Hugues Melliez et al.   CLINICAL INFECTIOUS DISEASES

HLA B*5701 status, disease progression, and response to antiretroviral therapy

(2016)   AIDS

Differential Escape Patterns within the Dominant HLA-B*57:03-Restricted HIV Gag Epitope Reflect Distinct Clade-Specific Functional Constraints

(2014) R. P. Payne et al.   JOURNAL OF VIROLOGY

JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants

(2014) Emilie Sundqvist et al.   PLoS Pathogens

Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes

(2010) Arthur Y. Kim et al.   GASTROENTEROLOGY

Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy

(2010) Sarah Gheuens et al.   JOURNAL OF NEUROVIROLOGY

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

(2010)   SCIENCE

A large French prospective cohort of HIV-infected patients: the Nadis Cohort

(2009) P Pugliese et al.   HIV MEDICINE